JCI
44
7
ESS
44
5
PYPL
49
4
RF
44
10
GD
42
4
STT
48
4
DHI
36
3
NWSA
69
4
SWK
53
4
V
70
14
XRX
48
2
JNJ
30
4
CF
47
5
STX
34
2
ORCL
49
3
HOG
29
4
BLK
47
3
HST
53
4
DOW
47
4
ROST
60
3
JCI
44
7
ESS
44
5
PYPL
49
4
RF
44
10
GD
42
4
STT
48
4
DHI
36
3
NWSA
69
4
SWK
53
4
V
70
14
XRX
48
2
JNJ
30
4
CF
47
5
STX
34
2
ORCL
49
3
HOG
29
4
BLK
47
3
HST
53
4
DOW
47
4
ROST
60
3
Financhill
Back

Atara Biotherapeutics 10K Form

Sell
37

ATRA
Atara Biotherapeutics

Last Price:
$11.27
Seasonality Move:
4.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATRA News And Ratings

See the #1 stock for the next 7 days that we like better than ATRA

ATRA Financial Statistics

Sales & Book Value

Annual Sales: $8.6M
Cash Flow: $-4M
Price / Cash Flow: 0
Annual Sales: $-15.77
Price / Book: 0

Profitability

EPS (TTM): -25.76000
Net Income (TTM): $-133.2M
Gross Margin: $-313K
Return on Equity: 0%
Return on Assets: -85.41%

Atara Biotherapeutics Earnings Forecast

Key Atara Biotherapeutics Financial Ratios

  • The Gross Profit Margin over the past 6 years for ATRA is -3.65%.
  • The Selling, General & Administrative Expenses for ATRA have been equal to 593.82% of Gross Profit Margin.
  • The Research & Development expenses have been 2,622.01% of Revenue.
  • The Interest Expense is -1.91% of Operating Income.
  • The Net Earning history of ATRA is -3,220.88% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

Atara Biotherapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ATRA
CUSIP: 046513
Website: atarabio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.59
Quick Ratio: 0.44

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ATRA Technical Analysis vs Fundamental Analysis

Sell
37
Atara Biotherapeutics (ATRA) is a Sell

Is Atara Biotherapeutics a Buy or a Sell?